Ignite Creation Date:
2025-12-25 @ 2:17 AM
Ignite Modification Date:
2025-12-29 @ 7:22 AM
Study NCT ID:
NCT00737360
Status:
TERMINATED
Last Update Posted:
2012-09-05
First Post:
2008-08-18
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Phase II Study of TAS-106 to Treat Head and Neck Cancer
Sponsor:
Taiho Pharmaceutical Co., Ltd.
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2008-08
Start Date Type:
None
Primary Completion Date:
2011-06
Primary Completion Date Type:
ACTUAL
Completion Date:
2012-02
Completion Date Type:
ACTUAL
First Submit Date:
2008-08-18
First Submit QC Date:
None
Study First Post Date:
2008-08-19
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2012-04-20
Results First Submit QC Date:
None
Results First Post Date:
2012-09-05
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2012-08-02
Last Update Post Date:
2012-09-05
Last Update Post Date Type:
ESTIMATED